Petrichor Healthcare Capital Management
Petrichor Healthcare Capital Management provide customized investment structures and support.
Business Model:
Revenue: $0
Employees: 0-0
Rankings
Industries / Tags:
Detailed Petrichor Healthcare Capital Management Information
Geographic Data
Address: 399 Park Ave Fl 6
City: New York
State: NY
Zip: 10022
Country: US
Financial Info
Stage:
Raised Last:
$0
Raised Total:$410M
Social
Linkedin
Crunchbase
Metrics
10,054,106Website Global Rank
49Website Monthly Traffic
Twitter Followers
Description
Petrichor Healthcare Capital Management is a private equity firm that focuses on investing in the healthcare sector.
Contact Phone:
+19175137588
Contact Email:
| Announced Date | Company | Transaction | Money Raised |
|---|---|---|---|
| 6/2021 | Leukocare | Debt | 15M |
| 9/2022 | Fennec Pharmaceuticals | Post-IPO Debt | 20M |
| 11/2022 | Fennec Pharmaceuticals | Post-IPO Equity | 25M |
| 8/2022 | Fennec Pharmaceuticals | Post-IPO Equity | 0 |
| 12/2020 | ClearPoint Neuro | Convertible Note | 7.5M |
| 1/2023 | Vero Biotech | Venture Round | 30M |
| 1/2020 | ClearPoint Neuro | Equity | 17.5M |
| 10/2019 | Persivia | Series C | 0 |
| 10/2019 | CorneaGen | Debt Financing | 0 |
| 6/2021 | Leukocare | Equity | 2.5M |
| 4/2021 | Isotopen Technologien München | Convertible Note | 0 |
| 1/2023 | Palvella Therapeutics | Series D | 37.7M |
| 4/2022 | Aurion Biotechnologies | Venture Round | 120M |
| 8/2022 | Fennec Pharmaceuticals | Post-IPO Equity | 0 |
| 4/2022 | Aurion Biotechnologies | Venture Round | 0 |
| 6/2021 | Leukocare | Debt Financing | 0 |
| 6/2021 | Leukocare | Venture Round | 0 |
| 4/2021 | Isotopen Technologien München | Convertible Note | 0 |
| 12/2020 | ClearPoint Neuro | Post-IPO Equity | 0 |
| 1/2020 | ClearPoint Neuro | Post-IPO Equity | 0 |
| 10/2019 | Persivia | Series C | 0 |
| 10/2019 | CorneaGen | Debt Financing | 0 |
Startup Industries
Startup Locations
Portfolio Current Status
Portfolio Employee Count
| Name | Price |
|---|
| Name | Size | Announced Date |
|---|
